Placebo to ARGX-117 IV, ARGX-117, ARGX-117
ARGX-117-2003
Phase 2 small_molecule active
Quick answer
Placebo to ARGX-117 IV, ARGX-117, ARGX-117 for Multifocal Motor Neuropathy is a Phase 2 program (small_molecule) at Argenx with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Argenx
- Indication
- Multifocal Motor Neuropathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active